Connection

DAVID ROWLEY to Humans

This is a "connection" page, showing publications DAVID ROWLEY has written about Humans.
Connection Strength

0.384
  1. Androgen receptor variant-7 regulation by tenascin-c induced src activation. Cell Commun Signal. 2022 08 10; 20(1):119.
    View in: PubMed
    Score: 0.021
  2. ELF3 mediates IL-1a induced differentiation of mesenchymal stem cells to inflammatory iCAFs. Stem Cells. 2021 12; 39(12):1766-1777.
    View in: PubMed
    Score: 0.020
  3. Stromal TGF-? signaling induces AR activation in prostate cancer. Oncotarget. 2014 Nov 15; 5(21):10854-69.
    View in: PubMed
    Score: 0.012
  4. RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A. 2014 Nov 18; 111(46):16389-94.
    View in: PubMed
    Score: 0.012
  5. Reprogramming the tumor stroma: a new paradigm. Cancer Cell. 2014 Oct 13; 26(4):451-2.
    View in: PubMed
    Score: 0.012
  6. WFDC1 is a key modulator of inflammatory and wound repair responses. Am J Pathol. 2014 Nov; 184(11):2951-64.
    View in: PubMed
    Score: 0.012
  7. Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis. Am J Pathol. 2014 Jun; 184(6):1860-70.
    View in: PubMed
    Score: 0.012
  8. The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer. 2012 Dec; 19(6):R187-204.
    View in: PubMed
    Score: 0.011
  9. The WFDC1 gene: role in wound response and tissue homoeostasis. Biochem Soc Trans. 2011 Oct; 39(5):1455-9.
    View in: PubMed
    Score: 0.010
  10. The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation. 2011 Nov-Dec; 82(4-5):200-10.
    View in: PubMed
    Score: 0.010
  11. Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol. 2011 Jan; 178(1):79-87.
    View in: PubMed
    Score: 0.009
  12. TGF-?1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One. 2010 Oct 29; 5(10):e13751.
    View in: PubMed
    Score: 0.009
  13. Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2. J Surg Res. 2009 Sep; 156(1):155-60.
    View in: PubMed
    Score: 0.008
  14. Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate. 2009 Mar 01; 69(4):373-84.
    View in: PubMed
    Score: 0.008
  15. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7593-603.
    View in: PubMed
    Score: 0.008
  16. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology. 2008 Jul; 72(1):205-13.
    View in: PubMed
    Score: 0.008
  17. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Oncogene. 2008 Jan 17; 27(4):450-9.
    View in: PubMed
    Score: 0.007
  18. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005 Oct 01; 65(19):8887-95.
    View in: PubMed
    Score: 0.006
  19. Transforming growth factor-beta1 induced myofibroblasts regulate LNCaP cell death. J Urol. 2004 Dec; 172(6 Pt 1):2421-5.
    View in: PubMed
    Score: 0.006
  20. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate. 2004 Oct 01; 61(2):182-91.
    View in: PubMed
    Score: 0.006
  21. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 2004 Sep 01; 64(17):6082-90.
    View in: PubMed
    Score: 0.006
  22. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4792-801.
    View in: PubMed
    Score: 0.006
  23. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res. 2003 Sep 15; 63(18):5859-65.
    View in: PubMed
    Score: 0.006
  24. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res. 2002 Nov 01; 62(21):6021-5.
    View in: PubMed
    Score: 0.005
  25. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002 Sep; 8(9):2912-23.
    View in: PubMed
    Score: 0.005
  26. Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients. Cells. 2022 07 29; 11(15).
    View in: PubMed
    Score: 0.005
  27. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 2002 Jun 01; 62(11):3298-307.
    View in: PubMed
    Score: 0.005
  28. Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis. Hum Pathol. 2022 04; 122:84-91.
    View in: PubMed
    Score: 0.005
  29. Reactive stroma in prostate cancer progression. J Urol. 2001 Dec; 166(6):2472-83.
    View in: PubMed
    Score: 0.005
  30. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate. 2001 Nov 01; 49(3):213-23.
    View in: PubMed
    Score: 0.005
  31. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT. J Clin Invest. 2021 02 15; 131(4).
    View in: PubMed
    Score: 0.005
  32. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One. 2020; 15(12):e0244587.
    View in: PubMed
    Score: 0.005
  33. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers. Mamm Genome. 2000 Sep; 11(9):767-73.
    View in: PubMed
    Score: 0.005
  34. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance. Clin Cancer Res. 2019 12 01; 25(23):6916-6924.
    View in: PubMed
    Score: 0.004
  35. UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression. Oncogene. 2020 04; 39(15):3089-3101.
    View in: PubMed
    Score: 0.004
  36. Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung. Nat Commun. 2019 05 13; 10(1):2131.
    View in: PubMed
    Score: 0.004
  37. Moving Beyond Gleason Scoring. Arch Pathol Lab Med. 2019 05; 143(5):565-570.
    View in: PubMed
    Score: 0.004
  38. The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability. Cancer Cell. 2018 11 12; 34(5):823-839.e7.
    View in: PubMed
    Score: 0.004
  39. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues. J Histochem Cytochem. 1998 Mar; 46(3):379-88.
    View in: PubMed
    Score: 0.004
  40. Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus. J Infect Dis. 2018 01 30; 217(4):538-547.
    View in: PubMed
    Score: 0.004
  41. What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 1998-1999; 17(4):411-9.
    View in: PubMed
    Score: 0.004
  42. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG. Oncotarget. 2017 Jul 04; 8(27):44447-44464.
    View in: PubMed
    Score: 0.004
  43. A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis. Neoplasia. 2017 May; 19(5):421-428.
    View in: PubMed
    Score: 0.004
  44. Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3). Hum Pathol. 2017 05; 63:202-211.
    View in: PubMed
    Score: 0.004
  45. Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget. 2016 Dec 13; 7(50):82609-82619.
    View in: PubMed
    Score: 0.004
  46. Neuronal Trans-Differentiation in Prostate Cancer Cells. Prostate. 2016 10; 76(14):1312-25.
    View in: PubMed
    Score: 0.003
  47. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer. Oncogene. 2017 02 02; 36(5):618-627.
    View in: PubMed
    Score: 0.003
  48. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations. Mol Cancer Res. 2016 Apr; 14(4):374-84.
    View in: PubMed
    Score: 0.003
  49. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action. Cancer Res. 1995 Feb 15; 55(4):781-6.
    View in: PubMed
    Score: 0.003
  50. Responding to moderate breaches in professionalism: an intervention for medical students. Med Teach. 2015 Feb; 37(2):136-9.
    View in: PubMed
    Score: 0.003
  51. FGFR1-WNT-TGF-? signaling in prostate cancer mouse models recapitulates human reactive stroma. Cancer Res. 2014 Jan 15; 74(2):609-20.
    View in: PubMed
    Score: 0.003
  52. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo. Clin Cancer Res. 2014 Jan 01; 20(1):100-9.
    View in: PubMed
    Score: 0.003
  53. Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6101-11.
    View in: PubMed
    Score: 0.003
  54. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther. 2013 Aug; 21(8):1611-20.
    View in: PubMed
    Score: 0.003
  55. Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. Ann Clin Lab Sci. 2013; 43(1):11-21.
    View in: PubMed
    Score: 0.003
  56. Application of the ICF to referral delay in total joint arthroplasty. Qual Saf Health Care. 2010 Dec; 19(6):e23.
    View in: PubMed
    Score: 0.002
  57. Amputation surgery--a plea for caution. J R Coll Surg Edinb. 1990 Apr; 35(2):112.
    View in: PubMed
    Score: 0.002
  58. Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res. 2009 Jun 15; 15(12):3979-89.
    View in: PubMed
    Score: 0.002
  59. Characterization of tumor-derived pancreatic stellate cells. J Surg Res. 2009 Nov; 157(1):96-102.
    View in: PubMed
    Score: 0.002
  60. WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection. J Virol. 2008 Jan; 82(1):471-86.
    View in: PubMed
    Score: 0.002
  61. Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapy. Cancer Res. 2007 Oct 15; 67(20):9613-5.
    View in: PubMed
    Score: 0.002
  62. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2007 Nov; 38(11):1611-20.
    View in: PubMed
    Score: 0.002
  63. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol. 2007 Feb; 38(2):299-307.
    View in: PubMed
    Score: 0.002
  64. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res. 2006 May 15; 66(10):5159-64.
    View in: PubMed
    Score: 0.002
  65. Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section. Am J Pathol. 2006 May; 168(5):1405-12.
    View in: PubMed
    Score: 0.002
  66. Bystin in perineural invasion of prostate cancer. Prostate. 2006 Feb 15; 66(3):266-72.
    View in: PubMed
    Score: 0.002
  67. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate. 2005 Nov 01; 65(3):276-86.
    View in: PubMed
    Score: 0.002
  68. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate. 2004 Oct 01; 61(2):192-9.
    View in: PubMed
    Score: 0.002
  69. Glutathione S-transferase pi is upregulated in the stromal compartment of hormone independent prostate cancer. Prostate. 2003 Jul 01; 56(2):98-105.
    View in: PubMed
    Score: 0.001
  70. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urol Oncol. 2003 May-Jun; 21(3):197-205.
    View in: PubMed
    Score: 0.001
  71. Neuroepithelial interactions in prostate cancer are enhanced in the presence ofprostatic stroma. Urology. 2003 Apr; 61(4):870-5.
    View in: PubMed
    Score: 0.001
  72. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Mol Ther. 2000 Sep; 2(3):211-7.
    View in: PubMed
    Score: 0.001
  73. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter. Anticancer Res. 2000 Sep-Oct; 20(5A):2811-6.
    View in: PubMed
    Score: 0.001
  74. Using the MEDLINE database in a histology laboratory. Acad Med. 1995 May; 70(5):439-40.
    View in: PubMed
    Score: 0.001
  75. Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors. Endocrinology. 1988 Jul; 123(1):601-10.
    View in: PubMed
    Score: 0.000
  76. A common molecular weight of the androgen receptor monomer in different target tissues. Biochemistry. 1987 Jun 02; 26(11):3174-82.
    View in: PubMed
    Score: 0.000
  77. Characterization of steroid receptors in human prostate using mibolerone. Prostate. 1986; 8(3):241-53.
    View in: PubMed
    Score: 0.000
  78. Structure and biochemistry of the Sertoli cell. Int Rev Cytol. 1985; 94:127-49.
    View in: PubMed
    Score: 0.000
  79. Physicochemical characterization of the androgen receptor from hyperplastic human prostate. Prostate. 1984; 5(6):567-79.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.